The firm’s success culminated with an acquisition by Amárach Research. Then, London called. Wendy landed a job as Commercial Analyst at GSK in a global product role.

Yet, just as she was settling into her new life, GSK went through a massive restructure. Fear initially took hold, but only momentarily, as Wendy transitioned into a customer insights director role. She went on to support the launch of marketing campaigns for a new Respiratory medicine via customer insight testing and input. And In 2017, she became a Global Marketing Director, where she worked with a global launch team designing and setting strategy for respiratory medicine in US, Europe and Japan.

Wendy is motivated by the challenge of working at the interface of the medical and marketing sides of the business. “There is nothing more important to me than patient health, so one of the more interesting parts of job is working in this highly regulated area; how you do you market a licenced product in a fair and balanced way so that it gets to the appropriate patient where it can do a lot of good?”

Last summer, the pandemic presented Wendy with a new opportunity. Today, she is helping to shape and determine GSK’s vaccine development plans. “It’s a very different challenge to what I’ve done before: help the business make good investment decisions that will advance vaccines with the greatest potential to impact public health to the next stages.

This pandemic has challenged pharmaceutical companies to pivot. It’s been more dynamic than anything we’ve seen. All parties found efficient paths to get vaccine to patients in a speedier way to address the huge public health need. It’s pushed the pharma industry to innovate, and it will be interesting to see the implications on everything else we have to face into the future. I look forwards to seeing that!”